Shue Youe Kong 4
4 · OPTIMER PHARMACEUTICALS INC · Filed May 18, 2009
Insider Transaction Report
Form 4
Shue Youe Kong
VP, clinical Development
Transactions
- Other
Common stock
2009-05-15$7.22/sh+1,491$10,772→ 78,552 total
Footnotes (1)
- [F1]Acquired under the Company's employee stock purchase plan on May 15, 2009.